Form 4: Kiniksa Pharmaceuticals CFO Mark Ragosa Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer Mark Ragosa of Kiniksa Pharmaceuticals, Ltd. reports acquisition and disposal of Class A Common Shares and Restricted Share Units.
Summary
- On April 1, 2024, Mark Ragosa, the CFO of Kiniksa Pharmaceuticals, acquired 1,750 Class A Common Shares through the vesting of Restricted Share Units (RSUs).
- Also on April 1, 2024, Ragosa disposed of 514 Class A Common Shares to cover tax obligations at a price of $19.7 per share.
- Following these transactions, Ragosa directly owns 16,868 Class A Common Shares and 5,250 Restricted Share Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is standard practice for officers of publicly traded companies to report changes in their beneficial ownership of company stock.
Comparison to Industry Standards
- Form 4 filings are a standard regulatory requirement for company insiders in the US, ensuring transparency in line with SEC regulations.
- Similar filings are required of insiders at comparable pharmaceutical companies such as Amgen, Biogen, and Regeneron, whenever they trade in their company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
- The transactions have no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Grant date of the Restricted Share Units, vesting over a four-year period. |
| 04/01/2024 | Date of transaction: Acquisition of shares through RSU vesting and disposal of shares for tax obligations. |
| 04/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.